Both in Pharmaceuticals
Edesa Biotech vs Context Therapeutics
Over the past year EDSA returned +6.2% and CNTX returned −82.2%; their daily moves had a correlation of 0.05.
EDSA +6.2% CNTX −82.2%Growth of $1, one year, split-adjusted
| Metric | EDSA | CNTX |
|---|---|---|
| Price | $2.57 | $0.2440 |
| Market cap | $24.8M | $22.4M |
| Today | −3.75% | +1.46% |
| 1 month | −37.9% | −36.4% |
| 6 months | −56.7% | −90.0% |
| Year to date | +81.0% | −83.4% |
| 1 year | +1.2% | −81.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.3M | $43.0M |
| Dividend yield | — | — |
| Volatility (60d) | 89.2% | 94.4% |
| Short % of float | 2.8% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).